BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 727132)

  • 1. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes ventricular tachycardia. A complication of disopyramide shared with quinidine.
    Wald RW; Waxman MB; Colman JM
    J Electrocardiol; 1981 Jul; 14(3):301-7. PubMed ID: 7264507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia with torsade de pointes morphology induced by oral disopyramide.
    Commerford PJ; Beck W
    S Afr Med J; 1980 Sep; 58(11):447-8. PubMed ID: 7404173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Forester D
    Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
    Mason JW; Winkle RA
    Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases.
    Dhurandhar RW; Nademanee K; Goldman AM
    Heart Lung; 1978; 7(5):783-7. PubMed ID: 250503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atypical ventricular tachycardia due to disopyramide].
    Feigl D; Ashkenazi J; Schwarzmann H
    Harefuah; 1982 Mar; 102(6):246-7. PubMed ID: 7160719
    [No Abstract]   [Full Text] [Related]  

  • 10. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procainamide, disopyramide and quinidine: discordant antiarrhythmic effects during crossover comparison in patients with inducible ventricular tachycardia.
    Wyse DG; Mitchell LB; Duff HJ
    J Am Coll Cardiol; 1987 Apr; 9(4):882-9. PubMed ID: 3558987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
    Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
    Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia.
    Wellens HJ; Bär FW; Lie KI; Düren DR; Dohmen HJ
    Am J Cardiol; 1977 Oct; 40(4):579-85. PubMed ID: 910721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
    Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
    Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular pacing in atypical ventricular tachycardia.
    Keren A; Tzivoni D; Golhman JM; Corcos P; Benhorin J; Stern S
    J Electrocardiol; 1981; 14(2):201-5. PubMed ID: 7276791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
    Waxman HL; Buxton AE; Sadowski LM; Josephson ME
    Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disopyramide-induced ventricular tachycardia.
    Lo KS; Gantz KB; Stetson PL; Lucchesi BR; Pitt B
    Arch Intern Med; 1980 Mar; 140(3):413-4. PubMed ID: 6153888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Three cases of torsades de pointes due to anti-arrhythmic agents].
    Yasuda M; Toda I; Akioka K; Teragaki M; Oku H; Takeuchi K; Takeda T; Inoue E; Ikuno Y; Horiguchi T
    Nihon Naika Gakkai Zasshi; 1986 Sep; 75(9):1262-6. PubMed ID: 3794468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.